Arvind Sahu

4.3k total citations
87 papers, 3.4k citations indexed

About

Arvind Sahu is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Arvind Sahu has authored 87 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Immunology, 26 papers in Epidemiology and 23 papers in Molecular Biology. Recurrent topics in Arvind Sahu's work include Complement system in diseases (47 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Herpesvirus Infections and Treatments (14 papers). Arvind Sahu is often cited by papers focused on Complement system in diseases (47 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Herpesvirus Infections and Treatments (14 papers). Arvind Sahu collaborates with scholars based in India, United States and Greece. Arvind Sahu's co-authors include John D. Lambris, Michael K. Pangburn, Jayati Mullick, Brian K. Kay, Athena M. Soulika, Dimitrios Morikis, Akhilesh K. Singh, William T. Moore, Ioannis K. Zarkadis and J. Oriol Sunyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Arvind Sahu

84 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Arvind Sahu 2.1k 696 680 462 437 87 3.4k
Peter J. Lachmann 1.7k 0.8× 669 1.0× 311 0.5× 363 0.8× 595 1.4× 86 3.1k
Nicole M. Thielens 4.2k 2.0× 1.5k 2.2× 690 1.0× 675 1.5× 1.1k 2.6× 182 6.2k
David E. Isenman 2.4k 1.1× 1.2k 1.7× 301 0.4× 948 2.1× 766 1.8× 76 3.7k
Georgia Sfyroera 1.3k 0.6× 554 0.8× 337 0.5× 137 0.3× 262 0.6× 44 2.2k
M D Cooper 1.5k 0.7× 690 1.0× 459 0.7× 398 0.9× 219 0.5× 74 2.9k
Periasamy Selvaraj 2.3k 1.1× 1.3k 1.8× 805 1.2× 772 1.7× 218 0.5× 151 4.8k
Rory M. Marks 1.2k 0.6× 1.9k 2.7× 382 0.6× 372 0.8× 284 0.6× 31 4.5k
Jean‐Pierre Vaerman 1.2k 0.6× 1.0k 1.5× 460 0.7× 668 1.4× 233 0.5× 90 3.4k
Russell D. Salter 4.3k 2.1× 2.2k 3.1× 561 0.8× 625 1.4× 158 0.4× 75 6.3k
Vineeta Bal 1.8k 0.8× 792 1.1× 422 0.6× 222 0.5× 108 0.2× 96 3.0k

Countries citing papers authored by Arvind Sahu

Since Specialization
Citations

This map shows the geographic impact of Arvind Sahu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Sahu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Sahu more than expected).

Fields of papers citing papers by Arvind Sahu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Sahu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Sahu. The network helps show where Arvind Sahu may publish in the future.

Co-authorship network of co-authors of Arvind Sahu

This figure shows the co-authorship network connecting the top 25 collaborators of Arvind Sahu. A scholar is included among the top collaborators of Arvind Sahu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind Sahu. Arvind Sahu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sahu, Arvind, et al.. (2025). Pro‐ and Anti‐Inflammatory Role of Complement in Cancer. European Journal of Immunology. 55(6). e51767–e51767. 2 indexed citations
2.
Ashokkumar, Kaliyaperumal, et al.. (2025). Complement C3 deficiency inhibits osteoclast differentiation and prevents ovariectomy-induced osteoporosis. The Journal of Immunology. 214(11). 3069–3082.
3.
Wang, Hailong, Arvind Sahu, Michael D. Chuong, & Ruiping Li. (2024). TCF4 as a potential prognostic biomarker and an anticancer target in gastric cancer. Translational Cancer Research. 13(9). 5073–5086. 2 indexed citations
4.
Wong, Vanessa, Richard de Boer, Belinda Yeo, et al.. (2022). Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study. Clinical Breast Cancer. 22(7). e764–e772. 1 indexed citations
5.
Ge, Xiaoxiao, Fengjuan Lin, Zheng Wu, et al.. (2022). Role of ROR2 in promoting gastric cancer metastasis by enhancing c-JUN-mediated MMP3 transcription. Annals of Translational Medicine. 10(20). 1117–1117. 4 indexed citations
6.
Sahu, Arvind, et al.. (2021). Differential expression of complement receptors CR1/2 and CR4 by murine M1 and M2 macrophages. Molecular Immunology. 137. 75–83. 7 indexed citations
7.
Panwar, Hemendra Singh, et al.. (2019). Structural basis of hypoxic gene regulation by the Rv0081 transcription factor of Mycobacterium tuberculosis. FEBS Letters. 593(9). 982–995. 7 indexed citations
8.
Khuperkar, Deepak, et al.. (2017). Selective recruitment of nucleoporins on vaccinia virus factories and the role of Nup358 in viral infection. Virology. 512. 151–160. 11 indexed citations
9.
Kumar, Jitendra, et al.. (2017). Complement Evasion Strategies of Viruses: An Overview. Frontiers in Microbiology. 8. 1117–1117. 116 indexed citations
10.
Mullick, Jayati, et al.. (2011). Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity. Vaccine. 29(43). 7435–7443. 11 indexed citations
11.
Sahu, Arvind, et al.. (2010). Identification of Complin, a Novel Complement Inhibitor that Targets Complement Proteins Factor B and C2. The Journal of Immunology. 184(12). 7116–7124. 7 indexed citations
12.
Soulika, Athena M., Dimitrios Morikis, Maria‐Rosa Sarrias, et al.. (2003). Studies of Structure-Activity Relations of Complement Inhibitor Compstatin. The Journal of Immunology. 171(4). 1881–1890. 30 indexed citations
13.
Sarrias, Maria‐Rosa, Silvia Franchini, Gabriela Canziani, et al.. (2001). Kinetic Analysis of the Interactions of Complement Receptor 2 (CR2, CD21) with Its Ligands C3d, iC3b, and the EBV Glycoprotein gp350/220. The Journal of Immunology. 167(3). 1490–1499. 70 indexed citations
14.
Sahu, Arvind, Athena M. Soulika, Dimitrios Morikis, et al.. (2000). Binding Kinetics, Structure-Activity Relationship, and Biotransformation of the Complement Inhibitor Compstatin. The Journal of Immunology. 165(5). 2491–2499. 91 indexed citations
15.
Soulika, Athena M., Mohammad M. Khan, Takashi Hattori, et al.. (2000). Inhibition of Heparin/Protamine Complex-Induced Complement Activation by Compstatin in Baboons. Clinical Immunology. 96(3). 212–221. 57 indexed citations
16.
Sahu, Arvind, J. Oriol Sunyer, William T. Moore, et al.. (1998). Structure, functions, and evolution of the third complement component and viral molecular mimicry. Immunologic Research. 17(1-2). 109–121. 22 indexed citations
17.
Sahu, Arvind & Michael K. Pangburn. (1995). Tyrosine is a potential site for covalent attachment of activated complement component C3. Molecular Immunology. 32(10). 711–716. 25 indexed citations
18.
Sahu, Arvind, et al.. (1993). Identification of multiple sites of interaction between heparin and the complement system. Molecular Immunology. 30(7). 679–684. 84 indexed citations
19.
Sehgal, Virendra, et al.. (1992). Anti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitro. International Journal of Immunopharmacology. 14(2). 269–273. 7 indexed citations
20.
Sahu, Arvind, et al.. (1988). Interaction of anti-leprosy drugs with the rat serum complement system. Immunopharmacology. 15(3). 143–150. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter J. Lachmann Breakdown of academic impact, for papers by Nicole M. Thielens Breakdown of academic impact, for papers by David E. Isenman Breakdown of academic impact, for papers by Georgia Sfyroera Breakdown of academic impact, for papers by M D Cooper Breakdown of academic impact, for papers by Periasamy Selvaraj Breakdown of academic impact, for papers by Rory M. Marks Breakdown of academic impact, for papers by Jean‐Pierre Vaerman Breakdown of academic impact, for papers by Russell D. Salter Breakdown of academic impact, for papers by Vineeta Bal
Rankless by CCL
2026